Lehman Financial Resources’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Lehman Financial Resources’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$162K	Buy	95,300 +14,500	+18%	+$26K	0.08%	97
2018 Q2	$140K	Buy	80,800 +10,000	+14%	+$17.3K	0.07%	82
2018 Q1	$129K	Buy	70,800 +2,500	+4%	+$5.28K	0.07%	78
2017 Q4	$152K	Buy	68,300 +54,800	+406%	+$136K	0.08%	77
2017 Q3	$39K	Buy	13,500 +3,500	+35%	+$11.9K	0.02%	68
2017 Q2	$43K	Buy	+10,000	New	+$41.2K	0.02%	62

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Lehman Financial Resources's SGYP Position: Q3 2018 in Review

Lehman Financial Resources increased its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 18% in Q3 2018, buying an estimated $26K and bringing the position to 95,300 shares worth $162K. The position accounts for 0.08% of the portfolio, ranked #97.

Lehman Financial Resources first reported a position in SGYP in Q2 2017 and has held it in 6 quarters since. 134 funds tracked by Wall St. Rank hold SGYP as of Q3 2018.

Lehman Financial Resources held 95,300 shares of Synergy Pharmaceuticals, Inc Common Stock worth $162K as of Q3 2018.
Lehman Financial Resources bought 14,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2018, an estimated $26K.
Synergy Pharmaceuticals, Inc Common Stock made up 0.08% of Lehman Financial Resources's portfolio in Q3 2018, its #97 holding.
Lehman Financial Resources first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2017 and has held it in 6 quarters since.
134 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2018.

Based on Lehman Financial Resources's 13F filing for Q3 2018, filed 14 Nov 2018.